William A. Sullivan

2012

In 2012, William A. Sullivan earned a total compensation of $849K as Chief Financial Officer and Treasurer at Merrimack Pharmaceuticals, a 65% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$100,640
Option Awards$485,200
Salary$254,862
Other$8,279
Total$848,981

Sullivan received $485.2K in option awards, accounting for 57% of the total pay in 2012.

Sullivan also received $100.6K in non-equity incentive plan, $254.9K in salary and $8.3K in other compensation.

Rankings

In 2012, William A. Sullivan's compensation ranked 6,777th out of 11,487 executives tracked by ExecPay. In other words, Sullivan earned more than 41.0% of executives.

ClassificationRankingPercentile
All
6,777
out of 11,487
41st
Division
Manufacturing
2,431
out of 4,253
43rd
Major group
Chemicals And Allied Products
615
out of 1,198
49th
Industry group
Drugs
420
out of 920
54th
Industry
Pharmaceutical Preparations
328
out of 700
53rd
Source: SEC filing on March 27, 2015.

Sullivan's colleagues

We found four more compensation records of executives who worked with William A. Sullivan at Merrimack Pharmaceuticals in 2012.

2012

Robert Mulroy

Merrimack Pharmaceuticals

Chief Executive Officer

2012

Ulrik Nielsen

Merrimack Pharmaceuticals

Chief Scientific Officer

2012

William McClements

Merrimack Pharmaceuticals

Head of Corporate Operations

2012

Edward Stewart

Merrimack Pharmaceuticals

Senior Vice President and President, Merrimack Healthcare Solutions

In-depth

You may also like